pharmaphorum

SEPTEMBER 27, 2022

Five wearable devices that monitor patients with Parkinson’s disease as they go about their lives have been given a provisional recommendation from NICE, making them available via the NHS while additional data is collected.

105

105

pharmaphorum

DECEMBER 2, 2021

Novartis has licensed a potential drug for Parkinson’s from Belgium’s UCB that it thinks could be the first oral, disease-modifying drug for the disease – if it can avoid the fate of earlier drugs in the class. The post Novartis takes aim at risky Parkinson’s target with $1.5bn UCB deal appeared first on.

Compounding 108

Compounding 108

BuzzRx

AUGUST 24, 2022

Deep brain stimulation (DBS) is one of the surgical treatments performed to treat Parkinson's disease. Abnormal electrical signals in the brain cause the motor complications seen in Parkinson’s disease. DBS surgery can relieve many of the debilitating symptoms related to motor function in Parkinson’s patients. How does it work?

FDA 98

FDA 98

pharmaphorum

JULY 20, 2021

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson’s disease which is currently in early-stage clinical testing.

FDA 98

FDA Communication Immunization 98

pharmaphorum

OCTOBER 29, 2021

AbbVie has reported that a subcutaneous infusion of Parkinson’s disease candidate ABBV-951 was more effective than standard oral therapy in a phase 3 trial, paving the way for regulatory filings. The post AbbVie preps filings after ABBV-951 tops oral Parkinson’s drugs in trial appeared first on. hours and 0.96

78

78

Digital Pharmacist

MARCH 28, 2024

Below we are sharing ways your pharmacy can learn more about how to participate in Parkinson’s Awareness Month. Educate Your Staff on Parkinson’s Disease Pharmacists are a constant in the lives of patients living with Parkinson’s Disease.

Health and Personal Care Stores 68

Health and Personal Care Stores Hospitals 68

pharmaphorum

MAY 23, 2022

AbbVie has filed for approval of its therapy for Parkinson’s disease, ABBV-951, which promises continuous control of symptoms and would be an alternative to current drugs that often fail to control symptoms throughout a 24-hour period. The post AbbVie files continuous Parkinson’s therapy ABBV-951 in US appeared first on.

52

52

pharmaphorum

NOVEMBER 4, 2022

Boehringer Ingelheim has appointed Lykke Hinsch Gylvin as its new head of medicine and chief medical officer, succeeding Mehdi Shahidi, who left the position earlier this year after three years in the role. “I am very much looking forward to working with my new colleagues and to continue transforming lives for generations.”

59

59

STAT

DECEMBER 7, 2023

AbbVie announced plans to purchase Cerevel Therapeutics and its pipeline of experimental neurological and psychiatric medications for $8.7 Remember, a prescription is not required. So no need to mess with rebates. Our choice today is chocolate raspberry. Meanwhile, here are a few items of interest. billion , STAT writes. The

91

91

Med Ed 101

JUNE 3, 2020

Parkinson’s disorder can be incredibly challenging to manage. The progression of the disease and its complications can make Parkinson’s very difficult for patients and clinicians. In addition to the disease itself, medication administration in Parkinson’s can provide additional hurdles to navigate.

40

40

Pharma Times

MARCH 31, 2022

In phase 2 trials, the drug reduced ‘OFF time’ which refers to periods of the day when Parkinson’s symptoms recur despite medication

47

47

pharmaphorum

MARCH 12, 2021

Many people with Parkinson’s have trouble falling or staying asleep at night,” says the Michael J. Sleep problems can arise from Parkinson’s motor or non-motor symptoms, medication side effects or other conditions that affect sleep,” it adds. Fox Foundation, which represents people with the disease.

Compounding 126

Compounding Communication 126

European Pharmaceutical Review

MAY 16, 2023

For the first time, we’ve discovered that stem cells can successfully treat the inflammation that causes heart failure” “For the first time, we’ve discovered that stem cells can successfully treat the inflammation that causes heart failure,” Dr Emerson C Perin, Medical Director at The Texas Heart Institute explained. “For

Hospitals 85

Hospitals 85

Hospital Pharmacy Europe

APRIL 15, 2024

It is the second trial of a GLP-1 RA diabetes drug to show an effect in Parkinson’s disease with a 2017 study reporting improvement in motor symptoms in patients taking exenatide. The latest study enrolled 156 people with early Parkinson’s disease and no motor complications.

Hospitals 59

Hospitals 59

Med Ed 101

SEPTEMBER 6, 2020

Parkinson’s disease can be very debilitating and not understanding how medications should be dosed can compound the problem. In Parkinson’s, we have a dopamine shortage. Let’s review the pharmacology briefly and why you need to be careful with Sinemet 10/100.

Compounding 40

Compounding 40

Med Ed 101

FEBRUARY 23, 2022

However, Parkinson’s cases present great difficulty to patients and clinicians, as our medical world lacks a solid understanding of the disease in comparison to other conditions. After Alzheimer’s disease, Parkinson’s is the second most prevalent neurodegenerative disease.

40

40

The Checkup by Singlecare

MARCH 8, 2024

However, it can come with undesirable side effects in the form of medication interactions. As a calcium channel blocker , this medication has been used for many years to manage heart rate in individuals with atrial fibrillation , atrial flutter , or supraventricular tachycardia (SVT). Besides these indications approved by the U.S.

Dosage 52

Dosage Labelling FDA 52

Pharma Mirror

AUGUST 12, 2020

These could include atrial fibrillation, atrial flutter, supraventricular tachycardia, and Wolff-Parkinson-White syndrome, among others. When used, the goal of these medications is. Antiarrhythmic drugs help counteract abnormal heart rhythms resulting from the irregular electrical activity.

52

52

Hospital Pharmacy Europe

JANUARY 11, 2024

The subcutaneous drug foslevodopa-foscarbidopa (brand name Produodopa) has been launched in the European Union (EU) for the treatment of advanced Parkinson’s disease, its manufacturer AbbVie has announced. On’ time signifies when symptoms are controlled, whereas ‘Off’ time occurs when symptoms return between medication doses. ‘On’

Labelling 99

Labelling Hospitals 99

pharmaphorum

JANUARY 3, 2023

“New therapeutic options are desperately needed for treatment-resistant schizophrenia that occurs in approximately one third of patients,” commented Ravi Anand, Newron’s chief medical officer. in the evenamide group. ” The new data could accelerate partnering efforts of the drug this year.

Labelling 105

Labelling 105

pharmaphorum

SEPTEMBER 20, 2021

” The technology could also be used to advance medical device-based therapeutics for treating motor dysfunctions in disorders like Parkinson’s disease or after a spinal cord injury, according to Inscopix. The post Lundbeck taps Inscopix’ brain-mapping camera tech for CNS research appeared first on.

Compounding 78

Compounding 78

PharmaShots

MAY 29, 2023

Parkinson's disease The collaboration will combine companies’ expertise and resources in developing NurrOn's ATH-399A & other compounds targeting Nurr1 for neurodegenerative disorders. Shots: The companies collaborated to discover & develop novel therapies for patients with neurodegenerative diseases incl.

Compounding 40

Compounding 40

The Checkup by Singlecare

OCTOBER 11, 2023

For example, you might offer guidance on proper dietary habits, lifestyle changes, and suitable medications. In some cases, pharmacists can also be the guiding voice to advise patients to consult their healthcare provider for medical advice. Medical conditions can also lead to constipation due to hormonal imbalances or other causes.

Dosage 52

Dosage 52

Med Ed 101

MAY 8, 2019

Parkinson’s is one of the most complex disease states you will encounter. The post Medication in Parkinson’s appeared first on Med Ed 101. The post Medication in Parkinson’s appeared first on Med Ed 101. However, we definitely know that dopamine plays a critical role in these […].

40

40

The People's Pharmacy

MAY 21, 2023

One factor that is often overlooked is medication. ” Levodopa: Another reader reported: “My husband has Parkinson’s disease and is taking levodopa. Anxiety, depression, sleep deprivation, post traumatic stress disorder (PTSD), sleep apnea and restless leg syndrome (RLS) have all been blamed. Do Drugs Cause Bad Dreams?

63

63

The Checkup by Singlecare

OCTOBER 16, 2023

If you or a loved one have recently been injured or diagnosed with an illness that impedes your daily life, you might wonder: What medical conditions automatically qualify you for disability? This means you must develop a severe medical ailment on the list of disabling conditions and then meet other criteria for each type of benefit.

Documentation 105

Documentation Immunization Mayo Clinic Insurance 105

The Checkup by Singlecare

JANUARY 11, 2024

Sumatriptan can interact with several medications, such as monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), and ergotamine. Before starting treatment with sumatriptan, consult a doctor or healthcare provider about other medications you take or medical conditions you have.

Compounding 52

Compounding Dosage FDA 52

Med Ed 101

JULY 4, 2018

They are often used in the management of restless leg syndrome and also sometimes utilized in Parkinson’s disease. Here’s a few clinical pearls on these medications that you should definitely know! The two common dopamine agonists used in practice are pramipexole (Mirapex) and ropinerole (Requip).

40

40

The Checkup by Singlecare

JANUARY 18, 2024

Key takeaways | Drug interactions | Food interactions | Other interactions | Avoiding interactions | When to see a doctor Albuterol (Ventolin HFA) is a quick-relief medication used to treat bronchospasm in people with asthma or chronic obstructive pulmonary disease (COPD). It is also effective in treating exercise-induced bronchospasm.

Dosage 52

Dosage 52

pharmaphorum

SEPTEMBER 15, 2021

The Patient Coalition for AI, Data and Digital Tech in Health has brought together members of patient organisations, medical colleges and health charities to tackle issues such as ensuring equitable access to digital health services. It is being sponsored by Boehringer Ingelheim.

107

107

The Checkup by Singlecare

JANUARY 9, 2024

The medication belongs to the anticholinergics class, but more specifically, it functions as an antispasmodic in IBS, relaxing smooth muscle spasms of the intestinal tract. Dicyclomine drug interactions The majority of what you need to watch out for is medication side effects that dicyclomine can magnify.

Labelling 52

Labelling Communication FDA 52

Roots Analysis

DECEMBER 10, 2023

Introduction In the ever-evolving landscape of medical advancements, a groundbreaking study conducted by Resonant, a Utah-based biotech company specializing in diagnostic tests for neurodegenerative diseases, is developing an Alzheimer’s blood test, a potential game-changer in the early detection of Alzheimer’s disease.

FDA 40

FDA 40

BuzzRx

JANUARY 5, 2023

In addition to these disorders, certain medications can cause drug-induced tremors. Please keep reading to find out which commonly prescribed medications can cause hand tremors as a side effect. Medication-induced tremor Certain medications can cause hand tremors as a side effect.

Dosage 52

Dosage 52

pharmaphorum

OCTOBER 17, 2021

According to John Krakauer, professor of neurology at Johns Hopkins University and chief medical advisor to MindMaze, the game “allows us to take full advantage of a unique but short window of opportunity to repair the nervous system after a stroke.” That study is targeting patients as early as one week after stroke.

Hospitals 59

Hospitals 59

PharmaShots

MARCH 6, 2023

For UCB it’s no longer simply about validating assumptions or having patients participate in market research; instead, it has become far more valuable to co-create solutions with patients that tackle the diverse challenges that matter most to them as individuals and their caregivers.

Immunization 40

Immunization Pharmaceutical Companies Pharmaceutical Companies Hospitals 40

pharmaphorum

FEBRUARY 2, 2021

Adamas Pharmaceuticals’ Parkinson’s drug Gocovri has a new indication as an adjunctive treatment for levodopa/carbodopa in patients with Parkinson’s disease experiencing ‘off’ episodes. This resulted in a clinically meaningful increase in good ON time in patients taking a levodopa-based medication for Parkinson’s disease.

Labelling 40

Labelling FDA 40

pharmaphorum

OCTOBER 7, 2021

Xenazine is associated with severe side effects including sedation, parkinsonism and the risk of depression and suicidality, and SOM reckons that its drug has a cleaner safety profile that could give it blockbuster potential. Treatment with the drug also achieved a three- or four-point reduction in TMC scores compared to control in 28.6%

Labelling 72

Labelling 72